You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

HYDERGINE LC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hydergine Lc, and what generic alternatives are available?

Hydergine Lc is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in HYDERGINE LC is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDERGINE LC?
  • What are the global sales for HYDERGINE LC?
  • What is Average Wholesale Price for HYDERGINE LC?
Summary for HYDERGINE LC
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 1
DailyMed Link:HYDERGINE LC at DailyMed
Drug patent expirations by year for HYDERGINE LC

US Patents and Regulatory Information for HYDERGINE LC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis HYDERGINE LC ergoloid mesylates CAPSULE;ORAL 018706-001 Jan 18, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for HYDERGINE LC

See the table below for patents covering HYDERGINE LC around the world.

Country Patent Number Title Estimated Expiration
Germany 3222250 ⤷  Sign Up
Philippines 22060 SOFT GELATIN CAPSULE WITH A LIQUID ERGOT ALKALOID CENTER FILL SOLUTION AND METHOD OF PREPARATION ⤷  Sign Up
Israel 66113 PHARMACEUTICAL SOFT-GELATIN CAPSULE FORMULATIONS CONTAINING ERGOPEPTIDE ALKALOIDS ⤷  Sign Up
Ireland 821489 ⤷  Sign Up
Finland 822187 ⤷  Sign Up
Austria A242282 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.